Leukaemia vaccine research
15 Oct, 2009
Robert Weinkove explains why he is developing a new immunotherapy for treating leukaemia that would stimulate the patient’s own immune system to fight the cancerous cells.
Listen to audio: Leukaemia vaccine research
Chronic lymphocytic leukaemia is the most common leukaemia in New Zealand. Currently, the only treatment is chemotherapy, which is often ineffective, or a bone marrow transplant.
Robert Weinkove is a haematologist working at Wellington Hospital and the Malaghan Institute of Medical Research. Here, he explains how a vaccine could be used to treat cancer.
Programme details: Our Changing World
- 27 October 2009